top of page

Maven E&L now has a forum!

Here in the UK I have been on "lock-down" and practicing my social distancing along with the rest of the population. This of course means that I have haven't been able to visit clients and future clients as I expected to. Indeed, I was due to fly to US on 30th March, clearly what wasn't possible, and I had instead like the anyone else had to make due with Zoom, Teams, Skype, Gotomeeting, Webex meetings instead. (Why does everyone use a different one – lots of healthy competition in that space!).

So whilst sitting in front of my PC, I thought about what I might be able to do further with my Website ( Well, I'm please to say I have now setup a custom E&L forum hosted on my Website for members. Membership is free .😊

Click here to join now

What I hope I can do is to encourage a few members and we can together make this a place for active discussion of all things E&L related. I have set up a few channels to get us going and will be granting membership and moderating the content.

The Current Channels are:

  • Beginner Guide to E&L

  • Fundamental Leachable Study Design Hints & Tips

  • Extractable Study Design Hints & Tips

  • ICH Q3E (what should be included)

Perhaps members can suggest other channels - Mass Spectrum of the month anyone? (a bit experimental?). Not sure about that one but idea might be for members to post a mass spectrum and others help to ID it.

I am also in the process of producing some paid content on the site for those who want it. It will consist of a series of presentations / video content which covers in more depth key topics in E&L. Hope to have that up and running soon.

I was thinking Topics such as:

· Regulatory Expectations for E&L

· Safety Risk Assessment Choices

· Quality by Design for E&L materials

· Risk Management of Leachables

· Complete guide to E&L method development & validation

I also wanted to let people know that about a JPAG meeting which is happening on the 7th May. As you would expect this is a virtual event.

The subject of the meeting is, “ICH Q3E (Extractables and Leachables): setting the scene”.

Here is the link

If you are interested (like me) in the future ICH Q3E I hope this will provide an opportunity to discuss key points and may be influence direction.

I will be providing a talk entitled, “Leachables Studies as an Exercise in Risk Management (Risk Assessment, Risk Control & Review)”. The format of the meeting has been geared towards making the most time for active discussion. Presenters have been asked to pre-record their presentations for review by attendees prior to the event. At the event, the presenters will give a 5 min summary of the presentation followed by a 15 min Q&A of the presentation. This seems to me an excellent format to make the most of the virtual environment and really adds value. Here the agenda:

  • ICH Process: how to influence (overview of Q3E)

Dr Dave Elder, JPAG/Consultant

  • Leachables Studies as an Exercise in Risk Management (Risk Assessment, Risk Control & Review)

Jason Creasey, Maven E&L, Consultant

  • Toxicological safety assessment of E&Ls

Chris Waine, BIBRA

  • E&L study design: analytical aspects: Similarities and differences in E&L testing for medicinal products and medical devices.

Dr Andrew Feilden, Hall Analytical

  • Lifecycle management; control strategies for E&Ls?

Dr Carsten Worsøe, Novo Nordisk, Denmark

  • ELSIE Consortium update: Safety based E&L Limits

Dr Andy Teasdale, AZ

  • Panel discussion: Opportunities and challenges in shaping ICH Q3E

Hope to see you all there.

Well that is all for this blog entry, I guess it's back to staring out of the window (and a bit of work too!). Hoping you all stay safe and well.

28 views0 comments

Recent Posts

See All

For those who are unaware, an expert working group is currently considering what to include within a new quality guidance document for E&L (extractables and leachables). It will have the designation I

bottom of page